
UT Horizon Fund
Description
The UT Horizon Fund is a distinctive strategic venture capital fund established by the University of Texas System. Launched with a significant commitment, its primary mission is to foster innovation and commercialization by investing in early- and middle-stage companies that demonstrate a direct connection to one of the UT System's institutions. This unique mandate positions the fund not merely as a financial investor but as a strategic partner aiming to leverage the vast intellectual capital and research capabilities residing within the UT System's universities and health institutions.
The fund's investment strategy is deeply rooted in supporting the entrepreneurial ecosystem emerging from the University of Texas. It specifically targets companies founded by UT faculty, students, or alumni, as well as ventures that are commercializing intellectual property licensed from UT System institutions. While sector-agnostic in principle, this focus naturally leads to investments in areas where UT excels, such as life sciences, deep technology, software, and advanced materials. The fund seeks companies with high growth potential, aiming to provide not just capital but also strategic guidance and access to the extensive UT network.
Financially, the UT Horizon Fund was established with a substantial $300 million allocation from the UT System's Permanent University Fund, underscoring the System's long-term commitment to this initiative. This capital enables the fund to make meaningful investments that can significantly impact a company's trajectory. Typical initial investments from the UT Horizon Fund range from $1 million to $5 million, with the flexibility and capacity to participate in subsequent funding rounds as portfolio companies scale. This approach ensures sustained support for promising ventures, contributing to both their success and the broader economic development within Texas and beyond.
Investor Profile
UT Horizon Fund has backed more than 32 startups, with 0 new investments in the last 12 months alone. The firm has led 4 rounds, about 13% of its total and boasts 7 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series A, Seed, Convertible Note rounds (top funding stages).
- Majority of deals are located in United States.
- Strong thematic focus on Health Care, Biotechnology, Medical.
- Typical check size: $1M – $5M.
Stage Focus
- Series A (25%)
- Seed (22%)
- Convertible Note (19%)
- Series B (13%)
- Series C (13%)
- Series Unknown (9%)
Country Focus
- United States (100%)
Industry Focus
- Health Care
- Biotechnology
- Medical
- Therapeutics
- Software
- Medical Device
- Information Technology
- Pharmaceutical
- Manufacturing
- Telecommunications
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.